Moreover, a single fraction of 16.4 Gy proton therapy induced a significant antitumor response in our cancer model, with tumor infiltration of different types of immune cells, such as CD8+ T cells, which express granzyme B+, translating cytotoxic activity. The gene discussed is GZMB; the disease is neoplasm.